Washington – The US Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved a wide range of therapies in 2023 that will help patients and consumers live better and possibly longer lives. Therapies For Many Types of Diseases and Conditions In 2023, CDER approved 55 novel drugs, as detailed in our annual New Drug Therapy Approvals report. The …
Research investment successfully delivers on several key milestones of the National Dementia Strategy Ottawa – Close to half a million people in Canada aged 65 and older live with dementia. As our population ages, that number is expected to increase. Researching brain health and age-related cognitive impairment will help us develop strategies to prevent dementia, discover new treatments, improve patient …
Ottawa – The Brain Health and Cognitive Impairment in Aging (BHCIA) Research Initiative is comprised of a comprehensive strategy, including a suite of funding opportunities that support research projects, people, and teams that, together, advance knowledge creation, training, and knowledge mobilization that will promote brain health during aging while addressing the complex care needs of people living with dementia and …
Washington – Robitussin cough syrup supplied nationally is being recalled by Haleon owing to microbial contamination that may cause fatal infections in susceptible individuals, the US division of the global consumer health company based in the UK announced this week. “Use of the recalled products could potentially result in severe or life-threatening fungal infections in those with impaired immune systems,” …
INDIANAPOLIS – Akouos, Inc., a wholly owned subsidiary of Eli Lilly and Company (NYSE: LLY), announced positive initial clinical results from the Phase 1/2 AK-OTOF-101 study, which demonstrated pharmacologic hearing restoration within 30 days of AK-OTOF administration in the first participant, an individual with a decade-plus history of profound hearing loss. Results, including initial data from a second participant to …
Ottawa – Bell Let’s Talk Day, an annual awareness campaign designed to help promote open conversations about mental health and well-being. This year’s theme, “Let’s create real change,” underscores the continued need to take action. While talking is a great starting point, for us, this initiative has always been about more than that. Together with a diversity of partners, we are …
Washington – At Moderna, experts say they are delivering on the promise of mRNA science to create a new generation of transformative medicines for patients. An mRNA can teach the body how to make a specific protein that can help your immune system prevent or treat certain diseases. Scientists have been studying mRNA for decades. And mRNA vaccines are just the start. Your body contains trillions …
Geneva – World Health Organisation (WHO) Director-General Tedros Adhanom Ghebreyesus called on countries to prepare for the new Disease X, at the World Economic Forum in Davos so that countries are well prepared before its arrival. Covid-19 took seven million lives in the world but warned that this new pandemic could be deadlier, and has the potential to kill 50 …
Ottawa – The Government of Canada is committed to ensuring the health and safety of Canadians which includes continuing to assess emerging risks in our environment such as plastic pollution. Plastic pollution and the health impact it may have is still an emerging area of research. Mark Holland, Minister of Health, announced funding of $2.1 million over four years to …
Ottawa – The group A streptococcus bacteria can cause many Group A streptococcal (GAS) diseases. Most illnesses are mild and may include: strep throat sinus infections skin or wound infections fever and rash (scarlet fever) In rare cases, a GAS infection can lead to invasive, more severe disease. This is known as invasive GAS or iGAS disease. These can include: …
